Skip to main content

Table 6 Vincristine relationship with other metabolic enzymes

From: Evaluation of the anticancer potential of CD44 targeted vincristine nanoformulation in prostate cancer xenograft model: a multi-dynamic approach for advanced pharmacokinetic evaluation

Parameter

Predicted value

Explanation

CYP2D6 inhibition

Yes (55%)

Predicts whether or not the compound is human CYP 2D6 inhibitor (Yes/No). Overall accuracy = 76%

CYP3A4 CLint

133.431

mg/min

Pooled atom-level intrinsic clearance in uL/min/mg HLM protein for CYP 3A4 mediated oxidation. RMSE/MAE = 0.67/0.53 log units

CYP3A4 human liver microsomes CLint

252.922

mg/min

Pooled atom-level intrinsic clearance in uL/min/mg HLM protein for CYP 3A4 mediated oxidation in human liver microsomes (unbound form). RMSE/MAE = 0.56/0.44 log units

CYP3A4 inhibition

Yes (80%)

Predicts whether or not the compound is human CYP 3A4 inhibitor (Yes/No). Overall accuracy = 78%

CYP3A4 Vmax

31.138

Moles/min

Kinetic Michaelis–Menten atom-level Vmax constants in nmol/min/(nmol of enzyme) for CYP 3A4 mediated oxidation. RMSE/MAE = 0.57/0.46 log units

CYP3A4 substrate

Yes (92%)

Predicts whether or not the compound is human CYP3A4 substrate (Yes/No). Overall accuracy = 82%

UGT1A3

Yes

Predicts whether or not the compound is substrate of UDP glucuronosyltransferase 1A3 (Yes/No). Overall accuracy = 86%